ABSTRACT Background Patients undergoing palatoplasty experience perioperative adverse events. Identifying risk factors for perioperative adverse events and escalation of care may improve outcomes. Methods Pediatric patients undergoing primary palatoplasty were included in this retrospective observational study performed at two academic children's ...
Febina Padiyath +17 more
wiley +1 more source
Effect of sugammadex on postoperative pulmonary complications in patients undergoing video-assisted thoracoscopic lung surgery. [PDF]
Tian L, Wang Y, Bu Y, Wang Y, Che G.
europepmc +1 more source
Sugammadex vs Neostigmine for Reversal of Neuromuscular Blockade and Association with Postoperative Atelectasis After Video-Assisted Thoracoscopic Surgery: A Propensity Score-Matched Cohort Study. [PDF]
Hung KC +6 more
europepmc +1 more source
Sugammadex for Neuromuscular Blockade Reversal and Postoperative Recovery in Laparoscopic Bariatric Surgery: A Randomized Controlled Trial. [PDF]
Wang QQ +5 more
europepmc +1 more source
Anesthetic Management of Traumatic Laryngotracheal Laceration in a Postpartum Patient: A Case Report. [PDF]
Malik NS, Mallya P, Singh A.
europepmc +1 more source
The Effect of Sugammadex Versus Neostigmine on Postoperative Cognitive Recovery: A Systematic Review and Meta-Analysis. [PDF]
Martins de Brito H +6 more
europepmc +1 more source
Deep neuromuscular blockade improves surgical conditions during laparoendoscopic single-site (LESS) surgery for total hysterectomy and reduces postoperative pain: a randomized controlled trial. [PDF]
Shen Y +6 more
europepmc +1 more source
Related searches:
Residual neuromuscular blockade Incidence and relevance
Der Anaesthesist, 2000Residual neuromuscular block is a major risk factor behind critical events in the immediate postoperative period. Residual weakness due to muscle relaxants is seen in more than thirds of postoperative patients with ventilatory failure and hypoxia. Residual neuromuscular block should therefore be regarded as a serious adverse event in the same way as we
Lars I Eriksson
exaly +3 more sources

